Volume 124, Issue 1, Pages 91-96 (January 2003) Model for end-stage liver disease (MELD) and allocation of donor livers  Russell Wiesner, Erick Edwards, Richard Freeman, Ann Harper, Ray Kim, Patrick Kamath, Walter Kremers, John Lake, Todd Howard, Robert M. Merion, Robert A. Wolfe, Ruud Krom  Gastroenterology  Volume 124, Issue 1, Pages 91-96 (January 2003) DOI: 10.1053/gast.2003.50016 Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 1 The relationship between the MELD score and CTP at time of listing on the OPTN waiting list. Patients with hepatocellular cancer or metabolic liver disease with a Child-Pugh score of less than 7 were excluded in the analysis. Gastroenterology 2003 124, 91-96DOI: (10.1053/gast.2003.50016) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 2 Estimated 3-month survival as a function of the MELD score. Gastroenterology 2003 124, 91-96DOI: (10.1053/gast.2003.50016) Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 3 The area under the receiving operating curve for the MELD score and CTP score with 3-month mortality as the end point. The difference was significant (P < 0.001). Dotted line represents the ROC based on chance alone and has a c-statistic of 0.5. Gastroenterology 2003 124, 91-96DOI: (10.1053/gast.2003.50016) Copyright © 2003 American Gastroenterological Association Terms and Conditions